The Short Report - May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more

Cindy Graham
May 19, 2021

Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada's nuclear leaders collaborate on the decommissioning process, and more.

... Please become a Member or login to read the rest of this article ...


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.